Literature DB >> 12384288

Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes.

Andreas Teufel1, Nasir Malik, Mahua Mukhopadhyay, Heiner Westphal.   

Abstract

The fibronectin type III (FNIII) repeat is one of three structural motifs originally identified in the fibronectin protein and has been well characterized in recent years. The consensus sequence has since been found in many different proteins including receptors and cell adhesion molecules. We report the cloning and expression analysis of Frcp1 and Frcp2, two members of a new FNIII repeat containing gene family. During embryonic development both genes are primarily expressed in the brain. In adult tissues, Frcp1 is strongly expressed in the liver and Frcp2 in the heart.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384288     DOI： 10.1016/s0378-1119(02)00828-4

Source DB:  PubMed          Journal:  Gene        ISSN： 0378-1119            Impact factor:   3.688


  54 in total

1.  Exercise in a bottle: Elucidating how exercise conveys health benefits might lead to new therapeutic options for a range of diseases from cancer to metabolic syndrome.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2016-01-08       Impact factor: 8.807

2.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

3.  Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway.

Authors:  Christiane D Wrann; James P White; John Salogiannnis; Dina Laznik-Bogoslavski; Jun Wu; Di Ma; Jiandie D Lin; Michael E Greenberg; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2013-10-10       Impact factor: 27.287

4.  SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) during exercise.

Authors:  Joseph P Tiano; Danielle A Springer; Sushil G Rane
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

Review 5.  On the Run for Hippocampal Plasticity.

Authors:  C'iana Cooper; Hyo Youl Moon; Henriette van Praag
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

6.  The structure of irisin reveals a novel intersubunit β-sheet fibronectin type III (FNIII) dimer: implications for receptor activation.

Authors:  Maria A Schumacher; Nagababu Chinnam; Tomoo Ohashi; Riddhi Sanjay Shah; Harold P Erickson
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

7.  Identification, cloning, and functional analysis of the TATA-less mouse FNDC5 promoter during neural differentiation.

Authors:  Tahere Seifi; Kamran Ghaedi; Sommayeh Tanhaei; Fereshteh Karamali; Abbas Kiani-Esfahani; Maryam Peymani; Hossein Baharvand; Mohammad-Hossein Nasr-Esfahani
Journal:  Cell Mol Neurobiol       Date:  2014-04-06       Impact factor: 5.046

8.  Central and peripheral irisin differentially regulate blood pressure.

Authors:  Weizhen Zhang; Lin Chang; Chao Zhang; Ruthann Zhang; Ziru Li; Biaoxin Chai; Jiyao Li; Eugene Chen; Michael Mulholland
Journal:  Cardiovasc Drugs Ther       Date:  2015-04       Impact factor: 3.727

Review 9.  A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases.

Authors:  Michael F Young; Sophia Valaris; Christiane D Wrann
Journal:  Prog Cardiovasc Dis       Date:  2019-03-04       Impact factor: 8.194

10.  Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.

Authors:  Timea Kurdiova; Miroslav Balaz; Marek Vician; Denisa Maderova; Miroslav Vlcek; Ladislav Valkovic; Miroslav Srbecky; Richard Imrich; Olga Kyselovicova; Vitazoslav Belan; Ivan Jelok; Christian Wolfrum; Iwar Klimes; Martin Krssak; Erika Zemkova; Daniela Gasperikova; Jozef Ukropec; Barbara Ukropcova
Journal:  J Physiol       Date:  2013-12-02       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.